bmiMD starts at $99/mo (all-in, includes medication); MEDVi at $179/mo (all-in, includes medication). Both prescribe GLP-1 medication — bmiMD offers compounded semaglutide & tirzepatide, MEDVi compounded semaglutide & tirzepatide. Here's how they compare on price, medications, support and transparency.
Bottom line: bmiMD wins
bmiMD wins on our rubric, 8.4/10 to 8.2/10. It leads most on value. Choose MEDVi instead if you prefer MEDVi — flat cash pricing across all 50 states, cheapest on a 12-month prepay.
Round by round
We scored both programs on the four factors in our methodology — value, support, medications and transparency. bmiMD takes 2, MEDVi takes 0, with 2 even. Here's how each shook out.
Value
What you get for the price — not just the lowest sticker. A premium program that includes FDA-approved medication, insurance help and real support can be good value. bmiMD scores 9.0 to 7.8 — clearly ahead.
Support
Real clinician access, coaching and follow-up — video visits and a care team score higher than async-only. bmiMD scores 8.2 to 8.0 — just ahead.
Medications
Medication options and legitimacy — FDA-approved branded (Wegovy, Zepbound) rates above compounded-only, and breadth and flexibility add points. Evenly matched at about 8.4.
Transparency
How clearly and publicly pricing, terms and availability are stated — plus track record and any regulatory red flags. Evenly matched at about 8.4.
Where they differ most
The clearest daylight is in value, where bmiMD leads 9.0 to 7.8. On price, bmiMD starts lower ($99 vs $179 per month).
Pricing: bmiMD vs MEDVi
bmiMD has the lower advertised starting price — $99/mo vs $179/mo for MEDVi. But read the fine print: bmiMD is all-in, includes medication and MEDVi is all-in, includes medication, and the cheapest rates often need a prepaid multi-month plan — so compare the real all-in cost at your maintenance dose, not the headline. We unpack how these plans are structured in how much compounded semaglutide costs.
bmiMD: On 12-month plan; $109 (6-mo) / $119 (3-mo) / $129–$159 month-to-month (as of 2026, glp1picks.com). MEDVi: On 12-month prepay; month-to-month is $299/mo; tirzepatide higher (as of 2026, health.usnews.com).
The specs, side by side
| bmiMD | MEDVi | |
|---|---|---|
| Editor rating | 8.4/10 · Very good | 8.2/10 · Very good |
| Starting price | $99/mo | $179/mo |
| Pricing | All-in, includes medication | All-in, includes medication |
| Medications | Compounded semaglutide & tirzepatide | Compounded semaglutide & tirzepatide |
| Medication form | Weekly injection | Weekly injection |
| Visit type | Telehealth consult + unlimited messaging | Async, ~24h provider review |
| Insurance | Cash-pay | Cash-pay (HSA/FSA) |
| Availability | 48 states (excl. LA, MS) | All 50 states |
Which should you pick?
Choose MEDVi if…
You prefer MEDVi — flat cash pricing across all 50 states, cheapest on a 12-month prepay.
View MEDVi plans →Common questions
Is bmiMD better than MEDVi?
In our scoring bmiMD comes out ahead — 8.4/10 to 8.2/10, leading on value. It's our pick for most people; MEDVi is the better choice if you prefer MEDVi — flat cash pricing across all 50 states, cheapest on a 12-month prepay.
Which is cheaper, bmiMD or MEDVi?
bmiMD has the lower advertised starting price — $99/mo vs $179/mo for MEDVi. But read the fine print: bmiMD is all-in, includes medication and MEDVi is all-in, includes medication, and the cheapest rates often need a prepaid multi-month plan — so compare the real all-in cost at your maintenance dose, not the headline.
Do bmiMD and MEDVi prescribe the same medications?
bmiMD offers compounded semaglutide & tirzepatide (weekly injection); MEDVi offers compounded semaglutide & tirzepatide (weekly injection). On breadth of options, bmiMD scores higher. Compounded GLP-1s aren't FDA-approved finished products, and availability shifts — confirm current options with each provider.
Which gives you more support, bmiMD or MEDVi?
bmiMD scores higher on support — real clinician access, coaching and follow-up. For visits, bmiMD is telehealth consult + unlimited messaging and MEDVi is async, ~24h provider review.
Are bmiMD and MEDVi legit?
Both require a licensed clinician to review your intake before prescribing. Confirm each provider's credentials, state availability (bmiMD: 48 states (excl. la, ms); MEDVi: all 50 states) and current pricing before you sign up — and note that compounded medications aren't FDA-approved.
Can I switch between bmiMD and MEDVi?
Generally yes — neither locks you into a long contract, though the lowest prices often require a prepaid plan. Never stop or change a GLP-1 medication without talking to your clinician first.
Both programs are scored with the same independent methodology. We may earn a commission from either provider — it changes nothing about the scores or the verdict. Prices are advertised starting rates as of October 2026; confirm current pricing with each provider. Nothing here is medical advice.